Updated ANCA-Associated Vasculitis Guidelines Aim to Improve Care
source: shutterstock.com

Updated ANCA-Associated Vasculitis Guidelines Aim to Improve Care

According to a story from Medscape, a new set of guidelines from the Kidney Disease: Improving Global Outcomes (KDIGO) aims to improve and update standards of care for antineutrophilic cytoplasmic…

Continue Reading Updated ANCA-Associated Vasculitis Guidelines Aim to Improve Care

Two Teenage Boys Diagnosed With ANCA-Associated Vasculitis, Part One

A group of autoimmune diseases called anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is the subject of a preprint under consideration at Pediatric Rheumatology. ANCA-AAV is characterized by damage to small…

Continue Reading Two Teenage Boys Diagnosed With ANCA-Associated Vasculitis, Part One
 Two Recent FDA and EMA Approvals Bring Hope to ANCA Associated-Vasculitis Patients
source: pixabay.com

 Two Recent FDA and EMA Approvals Bring Hope to ANCA Associated-Vasculitis Patients

   ANCA-associated vasculitis (AAV) generally targets two enzymes, myeloperoxidase (MPO) or proteinase 3 (PR3) located in the granules of monocytes and neutrophils. These enzymes play a critical role in the…

Continue Reading  Two Recent FDA and EMA Approvals Bring Hope to ANCA Associated-Vasculitis Patients
Approval Application for ANCA-Associated Vasculitis Drug Amended by Developer
source: pixabay.com

Approval Application for ANCA-Associated Vasculitis Drug Amended by Developer

According to a story from ANCA Vasculitis News, the biopharmaceutical company ChemoCentryx has recently made an amendment to its approval application for its investigational therapy. This therapy, called avacopan, is…

Continue Reading Approval Application for ANCA-Associated Vasculitis Drug Amended by Developer
Managing Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis
source: pixabay.com

Managing Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis

According to an article in Healio, Dr. Anisha Dua recently addressed attendees at the ACR Clinical Symposium on the subject of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Dr. Dua is the…

Continue Reading Managing Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis
Study of the Week: Nucala’s Effectiveness in EGPA Confirmed in Real-World Study
source: pixabay.com

Study of the Week: Nucala’s Effectiveness in EGPA Confirmed in Real-World Study

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Nucala’s Effectiveness in EGPA Confirmed in Real-World Study